Crossmark

Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study

Crossref DOI link: https://doi.org/10.1007/s11523-020-00773-3

Published Online: 2020-11-10

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Faloppi, Luca

Puzzoni, Marco

Gardini, Andrea Casadei

Silvestris, Nicola

Masi, Gianluca

Marisi, Giorgia

Vivaldi, Caterina

Gadaleta, Cosmo Damiano

Ziranu, Pina

Bianconi, Maristella

Loretelli, Cristian

Demurtas, Laura

Lai, Eleonora

Giampieri, Riccardo

Galizia, Eva

Ulivi, Paola

Battelli, Nicola

Falcone, Alfredo

Cascinu, Stefano

Scartozzi, Mario
License Information

Text and Data Mining valid from 2020-11-10

Version of Record valid from 2020-11-10
More Information

Article History

First Online: 10 November 2020

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below